Close menu



Cetuximab - Labelled (Arg,Lys) 13C15N


Quantification of Cetuximab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Cetuximab is a recombinant, stable isotope labelled, chimeric monoclonal antibody that is designed to be used as an internal standard for quantitative analysis of Cetuximab in plasma and tumour samples. Cetuximab is an epidermal growth factor receptor inhibitor for treatment of head and neck cancer, and colorectal cancer.

This product is for research use only and is not intended for diagnostic or therapeutic use.